{"DataElement":{"publicId":"3059901","version":"1","preferredName":"Infertility Treatment Type","preferredDefinition":"Text term to describe an action or administration of therapeutic agents to produce an effect that is intended to alter a woman's inability to produce children.","longName":"INFERT_TX_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2436694","version":"1","preferredName":"Infertility Treatment","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter a woman's inability to produce children.","longName":"INFTL_TX","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2436692","version":"1","preferredName":"Infertility","preferredDefinition":"The inability to produce children.","longName":"C3836","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infertility","conceptCode":"C3836","definition":"Inability to conceive for at least one year after trying and having unprotected sex. Causes of female infertility include endometriosis, fallopian tubes obstruction, and polycystic ovary syndrome. Causes of male infertility include abnormal sperm production or function, blockage of the epididymis, blockage of the ejaculatory ducts, hypospadias, exposure to pesticides, and health related issues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0781A8FE-5694-0C0C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"ONEDATA","dateModified":"2005-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2324753","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-2247-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-04","modifiedBy":"ONEDATA","dateModified":"2005-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008542","version":"1","preferredName":"Reproduction","preferredDefinition":"the patient's ability to conceive or nurse offspring and/or their current reproductive status.","longName":"REPRODUCTION","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227DAE6-EC15-4A7D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0781A8FE-5695-0C0C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3059894","version":"1","preferredName":"Infertility Treatment Type","preferredDefinition":"Inability to conceive for at least one year after trying and having unprotected sex. Causes of female infertility include endometriosis, fallopian tubes obstruction, and polycystic ovary syndrome. Causes of male infertility include abnormal sperm production or function, blockage of the epididymis, blockage of the ejaculatory ducts, hypospadias, exposure to pesticides, and health related issues._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Type; a subdivision of a particular kind of thing.","longName":"INFER_TX_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"32","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVF","valueDescription":"In vitro fertilization","ValueMeaning":{"publicId":"2698310","version":"1","preferredName":"In vitro fertilization","longName":"2698310","preferredDefinition":"Fertilization of an egg outside the body when the egg is normally fertilized in the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"In Vitro Fertilization","conceptCode":"C16580","definition":"Fertilization of an ovum outside of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FFCA565-C860-6FC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8446A1A4-42B8-2A88-E040-BB89AD43255A","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-15","modifiedBy":"ONEDATA","dateModified":"2010-04-15","deletedIndicator":"No"},{"value":"Letrozole","valueDescription":"Letrozole","ValueMeaning":{"publicId":"2921027","version":"1","preferredName":"Letrozole","longName":"2921027","preferredDefinition":"A nonsteroidal inhibitor of estrogen synthesis that resembles paclitaxel in chemical structure.  As a third-generation aromatase inhibitor, letrozole selectively and reversibly inhibits aromatase, a cytochrome P-450 enzyme complex found in many tissues including those of the premenopausal ovary, liver, and breast; aromatase catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis.  In estrogen-dependent breast cancers, ananstrozole may inhibit tumor growth. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Letrozole","conceptCode":"C1527","definition":"A nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F2A9285-CD52-5F08-E040-BB89AD435BDA","latestVersionIndicator":"Yes","beginDate":"2009-07-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8421565D-DAD8-203C-E040-BB89AD431340","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"ONEDATA","dateModified":"2010-04-13","deletedIndicator":"No"},{"value":"Clomid","valueDescription":"Clomid","ValueMeaning":{"publicId":"2577819","version":"1","preferredName":"Clomid","longName":"2577819","preferredDefinition":"A triphenylethylene nonsteroidal ovulatory stimulant evaluated for antineoplastic activity against breast cancer.  Clomiphene has both estrogenic and anti-estrogenic activities that compete with estrogen for binding at estrogen receptor sites in target tissues.  This agent causes the release of the pituitary gonadotropins follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to ovulation. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clomiphene Citrate","conceptCode":"C379","definition":"The citrate salt form of clomiphene, a triphenylethylene nonsteroidal ovulatory stimulant evaluated for antineoplastic activity against breast cancer. Clomiphene has both estrogenic and anti-estrogenic activities that compete with estrogen for binding at estrogen receptor sites in target tissues.  This agent causes the release of the pituitary gonadotropins follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to ovulation. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD08-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-21","modifiedBy":"REEVESD","dateModified":"2010-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8421565D-DAED-203C-E040-BB89AD431340","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"ONEDATA","dateModified":"2010-04-13","deletedIndicator":"No"},{"value":"IUI","valueDescription":"Intrauterine Insemination","ValueMeaning":{"publicId":"3059896","version":"1","preferredName":"Intrauterine Insemination","longName":"3059896","preferredDefinition":"Intrauterine Insemination","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8421565D-DAF8-203C-E040-BB89AD431340","latestVersionIndicator":"Yes","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8421565D-DB11-203C-E040-BB89AD431340","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"ONEDATA","dateModified":"2010-04-13","deletedIndicator":"No"},{"value":"Injectable Fertility Medication","valueDescription":"Injectable Fertility Medication","ValueMeaning":{"publicId":"3059899","version":"1","preferredName":"Injectable Fertility Medication","longName":"3059899","preferredDefinition":"Injectable Fertility Medication","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8421565D-DB6B-203C-E040-BB89AD431340","latestVersionIndicator":"Yes","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8421565D-DB84-203C-E040-BB89AD431340","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"ONEDATA","dateModified":"2010-04-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008542","version":"1","preferredName":"Reproduction","preferredDefinition":"the patient's ability to conceive or nurse offspring and/or their current reproductive status.","longName":"REPRODUCTION","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227DAE6-EC15-4A7D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3059893","version":"1","preferredName":"Infertility Therapy Type","preferredDefinition":"The inability to produce children.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:Type; a subdivision of a particular kind of thing.","longName":"C3836:C15368:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infertility","conceptCode":"C3836","definition":"Inability to conceive for at least one year after trying and having unprotected sex. Causes of female infertility include endometriosis, fallopian tubes obstruction, and polycystic ovary syndrome. Causes of male infertility include abnormal sperm production or function, blockage of the epididymis, blockage of the ejaculatory ducts, hypospadias, exposure to pesticides, and health related issues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8421565D-DA92-203C-E040-BB89AD431340","latestVersionIndicator":"Yes","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"ONEDATA","dateModified":"2010-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8421565D-DAA3-203C-E040-BB89AD431340","latestVersionIndicator":"Yes","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"CAMPBELB","dateModified":"2015-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812727","version":"1","longName":"U of Pa Cancer Center","context":"NCIP"},{"publicId":"2812574","version":"1","longName":"UPCC 07403","context":"NCIP"},{"publicId":"2812868","version":"1","longName":"U Pa Cancer Center New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Fertility Treatment Type","type":"Preferred Question Text","description":"Fertility Treatment Type","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8421565D-DB8E-203C-E040-BB89AD431340","latestVersionIndicator":"Yes","beginDate":"2010-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-13","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated to support U of Pennsylvania Fertility study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}